Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16297378 | 0.75 | GABRR1 (0.58) | GABRR1CA1CA2 | |
| SCHEMBL6593374 | 0.74 | MMP8 (0.43) | — | |
| SCHEMBL14896159 | 0.71 | SMN1; SMN2 (0.34) | CA1CA2 | |
| SCHEMBL6068166 | 0.69 | GABRR1 (0.50) | GABRR1CA1CA2 | |
| SCHEMBL7879761 | 0.68 | GABRR1 (0.54) | GABRR1 | |
| SCHEMBL4639637 | 0.68 | GABRR1 (0.54) | GABRR1 | |
| SCHEMBL30360217 | 0.66 | GABRR1 (0.52) | GABRR1 | |
| SCHEMBL31239060 | 0.66 | PRKCA (0.37) | CA1CA2 | |
| SCHEMBL28212355 | 0.66 | GABRR1 (0.52) | GABRR1 | |
| SCHEMBL28212354 | 0.66 | GABRR1 (0.52) | GABRR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3687561-A1 | \"IMMUNOREGULATORY MOLECULES AND USES THEREFOR\ | The Australian National University (AU) | 2020-08-05 | — | — | EP | disclosed |
| EP-3472192-A1 | SPIDER VENOM PEPTIDES AND METHODS OF USE FOR MODULATING SODIUM CHANNELS. | The University of Queensland (AU) | 2019-04-24 | — | — | EP | disclosed |
| WO-2019040994-A1 | \"IMMUNOREGULATORY MOLECULES AND USES THEREFOR\ | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 2019-03-07 | — | — | WO | disclosed |
| EP-3411061-A1 | PROTEINACEOUS COMPOUNDS AND USES THEREFOR | University of Canberra (AU) | 2018-12-12 | — | — | EP | disclosed |
| EP-3387007-A1 | PROTEINACEOUS MOLECULES AND METHODS OF USE | The University of Queensland (AU) | 2018-10-17 | — | — | EP | disclosed |
| WO-2017219081-A1 | SPIDER VENOM PEPTIDES AND METHODS OF USE FOR MODULATING SODIUM CHANNELS. | THE UNIVERSITY OF QUEENSLAND (AU) | 2017-12-28 | — | — | WO | disclosed |
| WO-2017132728-A1 | PROTEINACEOUS COMPOUNDS AND USES THEREFOR | UNIVERSITY OF CANBERRA (AU) | 2017-08-10 | — | — | WO | disclosed |
| WO-2017096431-A1 | PROTEINACEOUS MOLECULES AND METHODS OF USE | THE UNIVERSITY OF QUEENSLAND (AU) | 2017-06-15 | — | — | WO | disclosed |
| EP-2922862-A1 | COMPLEX-FORMATION-MODULATING AGENTS AND USES THEREFOR | Queensland University Of Technology (AU) | 2015-09-30 | — | — | EP | disclosed |
| WO-2014078896-A1 | COMPLEX-FORMATION-MODULATING AGENTS AND USES THEREFOR | QUEENSLAND UNIVERSITY OF TECHNOLOGY (AU) | 2014-05-30 | — | — | WO | disclosed |
| EP-2635596-A1 | IMMUNE-MODULATING AGENTS AND USES THEREFOR | UNIVERSITY OF TECHNOLOGY, SYDNEY (AU) | 2013-09-11 | — | — | EP | disclosed |
| WO-2012174591-A1 | PREVENTION AND TREATMENT OF ACUTE INFLAMMATORY CONDITIONS | THE UNIVERSITY OF QUEENSLAND (AU) | 2012-12-27 | — | — | WO | disclosed |
| WO-2012117336-A2 | APOPTOSIS-INDUCING MOLECULES AND USES THEREFOR | ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO MATERNO-INFANTILE BURLO GAROFOLO - OSPEDALE DI ALTA SPECIALIZZAZIONE E DI RILIEVO NAZIONALE PER LA SALUTE DELLA DONNA E DEL BAMBINO (IT) | 2012-09-07 | — | — | WO | disclosed |
| WO-2012071631-A1 | IMPROVED LIGHT-EMITTING MOLECULES | GENE STREAM PTY LTD (AU) | 2012-06-07 | — | — | WO | disclosed |
| WO-2012058715-A1 | IMMUNE-MODULATING AGENTS AND USES THEREFOR | UNIVERSITY OF TECHNOLOGY, SYDNEY (AU) | 2012-05-10 | — | — | WO | disclosed |
| EP-2231172-A1 | IMMUNOMODULATING COMPOSITIONS AND USES THEREFOR | Opal Therapeutics Pty Ltd (AU) | 2010-09-29 | — | — | EP | disclosed |
| WO-2009089568-A1 | IMMUNOMODULATING COMPOSITIONS AND USES THEREFOR | OPAL THERAPEUTICS PTY LTD (AU) | 2009-07-23 | — | — | WO | disclosed |
| EP-1222255-A4 | POLYPEPTIDE FRAGMENTS COMPRISING C-TERMINAL PORTION OF HELICOBACTER CATALASE | CSL LTD (AU) | 2004-03-31 | — | — | EP | disclosed |
| EP-1222255-A1 | POLYPEPTIDE FRAGMENTS COMPRISING C-TERMINAL PORTION OF HELICOBACTER CATALASE | CSL LIMITED (AU) | 2002-07-17 | — | — | EP | disclosed |
| WO-2001029198-A1 | POLYPEPTIDE FRAGMENTS COMPRISING C-TERMINAL PORTION OF HELICOBACTER CATALASE | CSL LIMITED (AU) | 2001-04-26 | — | — | WO | disclosed |